Nanotechnology for Age-Related Macular Degeneration

Nanotechnology for Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older. Today, the most common treatment for AMD involves repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs. However...

Full description

Bibliographic Details
Main Authors: Bo Yang, Ge Li, Jiaxin Liu, Xiangyu Li, Shixin Zhang, Fengying Sun, Wenhua Liu
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceutics
Subjects:
age-related macular degeneration (AMD)
nano-drug delivery system
cyclodextrin
CRISPR/Cas9
adeno-associated virus (AAV)
hyaluronic acid
Online Access:https://www.mdpi.com/1999-4923/13/12/2035

Internet

https://www.mdpi.com/1999-4923/13/12/2035

Similar Items